Full Press Release Details
Health Announces Pricing of $5 Million Public Offering
25 September 2025 08:01 PM
FL / ACCESS Newswire / September 25, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a leader in next-generation pharmaceutical
distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the pricing of a public offering of 7,142,862
shares of common stock, together with warrants to purchase up to 7,142,862 shares of common stock at a combined public offering price
of $0.70 per share and associated warrant. The warrants will have an exercise price of $0.70 per share, will be exercisable upon issuance
and will expire five years thereafter. The closing of the offering is expected to occur on or about September 29, 2025, subject to the
satisfaction of customary closing conditions.
Wainwright & Co. is acting as the exclusive placement agent for the offering.
gross proceeds to the Company from the offering are expected to be approximately $5 million, before deducting the placement agent's
fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from this offering for working capital
and general corporate purposes, which may include operating expenses, research and development, and pending and future acquisitions.
registration statement on Form S-1 (File No. 333-288932) relating to the offering was declared effective by the Securities and Exchange
Commission (the "SEC") on September 25, 2025. The offering is being made only by means of a prospectus forming part of the
effective registration statement relating to the offering. A preliminary prospectus relating to the offering has been filed with the
SEC. Electronic copies of the final prospectus, when available, may be obtained on the SEC's website at http://www.sec.gov
and may also be obtained, when available, by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022,
by phone at (212) 856-5711 or e-mail at placements@hcwco.com.
press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor
shall there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be
unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
Health, Inc. (NASDAQ:WGRX) delivers medications from manufacturer to patient-faster, smarter, and more affordably. Its integrated platform
connects more than 6,500 independent pharmacies and 200+ U.S. manufacturers, offering wholesale distribution, digital prescription routing,
and AI-driven hub services such as eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment. As a PBM-agnostic
alternative, Wellgistics Health provides compliant, end-to-end solutions designed to restore access, transparency, and trust in U.S.
press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals,
strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical
facts. When Wellgistics Health uses words such as "may," "will," "intend," "should,"
"believe," "expect," "anticipate," "project," "estimate," or similar expressions
that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without
limitation, statements regarding Wellgistics Health's strategy and descriptions of its future operations, prospects, and plans.
Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause actual results
to differ materially from Wellgistics Health's expectations discussed in the forward-looking statements. These statements are subject
to uncertainties and risks including, but not limited to, market conditions, the completion of the offering, the satisfaction of customary
closing conditions related to the offering, the intended use of net proceeds from the offering and other risks detailed in our reports
and statements filed with the SEC. Investors are cautioned not to place undue reliance upon any forward-looking statements in this press
release. Additional factors are discussed in Wellgistics Health's filings with the SEC, available at www.sec.gov.
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
Office: (646) 893-5835
Email: info@skylineccg.com
Wellgistics Health, Inc.